Descripción de diversos test para la valoración de la condición física en judo

En la literatura especializada no es fácil encontrar pruebas que aporten datos de judocas sobre la base de conductas motrices específicas de este deporte. Normalmente la condición física del judoca se evalúa a través de pruebas que provienen de otro tipo de deportes, particularmente de los deportes psicomotores, cuando el judo se incluye dentro de los deportes sociomotores (Parlebas, 2001). Al mismo tiempo, se emplean baterías como la batería EUROFIT (Conseil de L´Europe, 1989), para evaluar aspectos perceptivo-motrices. No obstante, durante los últimos años las investigaciones en el judo se han dirigido a desarrollar tests específicos para valorar parámetros fisiológicos, técnicos y/o perceptivo-motrices. En este sentido, en el presente artículo se describen algunas de las pruebas de valoración de la condición física que recoge la bibliografía occidental específica sobre esta materia. Una vez finalizado el análisis se concluye la necesidad de crear herramientas que recojan más variables de la realidad del enfrentamiento de competición y que puedan cumplir con los principios de fiabilidad, objetividad y reproductibilidad (López y cols. 2004) que todo test debe poseer, y que además sean sencillas y útiles para el entrenador

Sequential Loading of Cohesin Subunits during the First Meiotic Prophase of Grasshoppers

A previous version of this article appeared as an Early Online Release on January 2, 2007 (doi:10.1371/journal.pgen.0030028.eor).The cohesin complexes play a key role in chromosome segregation during both mitosis and meiosis. They establish sister chromatid cohesion between duplicating DNA molecules during S-phase, but they also have an important role during postreplicative double-strand break repair in mitosis, as well as during recombination between homologous chromosomes in meiosis. An additional function in meiosis is related to the sister kinetochore cohesion, so they can be pulled by microtubules to the same pole at anaphase I. Data about the dynamics of cohesin subunits during meiosis are scarce; therefore, it is of great interest to characterize how the formation of the cohesin complexes is achieved in order to understand the roles of the different subunits within them. We have investigated the spatio-temporal distribution of three different cohesin subunits in prophase I grasshopper spermatocytes. We found that structural maintenance of chromosome protein 3 (SMC3) appears as early as preleptotene, and its localization resembles the location of the unsynapsed axial elements, whereas radiation-sensitive mutant 21 (RAD21) (sister chromatid cohesion protein 1, SCC1) and stromal antigen protein 1 (SA1) (sister chromatid cohesion protein 3, SCC3) are not visualized until zygotene, since they are located in the synapsed regions of the bivalents. During pachytene, the distribution of the three cohesin subunits is very similar and all appear along the trajectories of the lateral elements of the autosomal synaptonemal complexes. However, whereas SMC3 also appears over the single and unsynapsed X chromosome, RAD21 and SA1 do not. We conclude that the loading of SMC3 and the non-SMC subunits, RAD21 and SA1, occurs in different steps throughout prophase I grasshopper meiosis. These results strongly suggest the participation of SMC3 in the initial cohesin axis formation as early as preleptotene, thus contributing to sister chromatid cohesion, with a later association of both RAD21 and SA1 subunits at zygotene to reinforce and stabilize the bivalent structure. Therefore, we speculate that more than one cohesin complex participates in the sister chromatid cohesion at prophase I.This work was supported by grants BFU2005–05668-C03–01, BFU2006–06655, BFU2005–01266, BFU2005–02431, and BFU2006–04406 from Ministerio de Educación y Ciencia, España, and grants 1001160016 and 11/BCB/013 from Universidad Autónoma de Madrid and Comunidad de Madrid. The Department of Immunology and Oncology was founded and is supported by the Spanish Council for Scientific Research (CSIC).Peer reviewe

PPARGC1A gene promoter methylation as a biomarker of insulin secretion and sensitivity in response to glucose challenges

Methylation in CpG sites of the PPARGC1A gene (encoding PGC1-α) has been associated with adiposity, insulin secretion/sensitivity indexes and type 2 diabetes. We assessed the association between the methylation profile of the PPARGC1A gene promoter gene in leukocytes with insulin secretion/sensitivity indexes in normoglycemic women. A standard oral glucose tolerance test (OGTT) and an abbreviated version of the intravenous glucose tolerance test (IVGTT) were carried out in n = 57 Chilean nondiabetic women with measurements of plasma glucose, insulin, and C-peptide. Bisulfite-treated DNA from leukocytes was evaluated for methylation levels in six CpG sites of the proximal promoter of the PPARGC1A gene by pyrosequencing (positions -816, -783, -652, -617, -521 and -515). A strong correlation between the DNA methylation percentage of different CpG sites of the PPARGC1A promoter in leukocytes was found, suggesting an integrated epigenetic control of this region. We found a positive association between the methylation levels of the CpG site -783 with the insulin sensitivity Matsuda composite index (rho = 0.31; p = 0.02) derived from the OGTT. The CpG hypomethylation in the promoter position -783 of the PPARGC1A gene in leukocytes may represent a biomarker of reduced insulin sensitivity after the ingestion of glucose

La Hora TutHora: una herramienta de ordenación académica para incrementar la acción tutorial en la Escuela Universitaria de Ingeniería Técnica Industrial de la UPM

La reciente puesta en marcha de las titulaciones adaptadas al RD 1393/2007 constituía la oportunidad largamente esperada de implementar una serie de proyectos ilusionantes asociados a la Declaración de Bolonia y a su “nebulosa”. Entre ellos, la mejora del rendimiento en la Acción Tutorial constituye, para la UPM, uno de los aspectos prioritarios. En ese ámbito, la E.U. de Ingeniería Técnica Industrial ha desarrollado, desde el curso 2010/2011, un proyecto denominado “La Hora TutHora”, cuyo objetivo consiste en actuar desde Ordenación Académica para favorecer la mencionada Acción Tutorial. Este artículo expone los resultados que han podido medirse tras un año de vida del proyecto

La Acción Tutorial incentivada durante los dos últimos cursos académicos con el proyecto de "La Hora Tuthora"

La puesta en marcha de las titulaciones adaptadas al RD 1393/2007 constituía la oportunidad largamente esperada de implementar una serie de proyectos ilusionantes asociados a la Declaración de Bolonia y a su “nebulosa”. Entre ellos, la mejora del rendimiento en la Acción Tutorial constituye, para la UPM, uno de los aspectos prioritarios. En ese ámbito, la E.U. de Ingeniería Técnica Industrial ha desarrollado, desde el curso 2010/2011, un proyecto denominado “La Hora TutHora”, cuyo objetivo consiste en actuar desde Ordenación Académica para favorecer la mencionada Acción Tutorial. Este artículo expone los resultados que han podido medirse tras dos años de vida del proyecto, las conclusiones que pueden obtenerse y el planteamiento de propuestas de mejora

Predictors of positive (18) F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica

Objective: Polymyalgia rheumatica (PMR) is often the presenting manifestation of giant cell arteritis (GCA). Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) scan often discloses the presence of large vessel vasculitis (LVV) in PMR patients. We aimed to identify predictive factors of a positive PET/CT scan for LVV in patients classified as having isolated PMR according to well-established criteria. Methods: A set of consecutive patients with PMR from a single hospital were assessed. All of them underwent PET/CT scan between January 2010 and February 2018 based on clinical considerations. Patients with PMR associated to other diseases, including those with cranial features of GCA, were excluded. The remaining patients were categorized in classic PMR (if fulfilled the 2012 EULAR/ACR classification criteria at disease diagnosis; n=84) or atypical PMR (who did not fulfill these criteria; n=16). Only information on patients with classic PMR was assessed. Results: The mean age of the 84 patients (51 women) with classic PMR was 71.4±9.2 years. A PET/CT scan was positive in 51(60.7%). Persistence of classic PMR symptoms was the most common reason to perform a PET/CT scan. Nevertheless, patients with positive PET/CT scan often had unusual symptoms. The best set of predictors of a positive PET/CT scan were bilateral diffuse lower limb pain (OR=8.8, 95% CI 1.7-46.3; p=0.01), pelvic girdle pain (OR=4.9, 95% CI 1.50-16.53; p=0.01) and inflammatory low back pain (OR=4.7, 95% CI 1.03-21.5; p=0.04). Conclusion: Inflammatory low back pain, pelvic girdle and diffuse lower limb pain are predictors of positive PET/CT scan for LVV in PMR

Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune Mediated Inflammatory Diseases. A Multicenter Study

We aimed to assess the e cacy of biologic therapy in refractory non-Multiple Sclerosis (MS) Optic Neuritis (ON), a condition more infrequent, chronic and severe than MS ON. This was an open-label multicenter study of patients with non-MS ON refractory to systemic corticosteroids and at least one conventional immunosuppressive drug. The main outcomes were Best Corrected Visual Acuity (BCVA) and both Macular Thickness (MT) and Retinal Nerve Fiber Layer (RNFL) using Optical Coherence Tomography (OCT). These outcome variables were assessed at baseline, 1 week, and 1, 3, 6 and 12 months after biologic therapy initiation. Remission was defined as the absence of ON symptoms and signs that lasted longer than 24 h, with or without an associated new lesion on magnetic resonance imaging with gadolinium contrast agents for at least 3 months. We studied 19 patients (11 women/8 men; mean age, 34.8 13.9 years). The underlying diseases were Bechet?s disease (n = 5), neuromyelitis optica (n = 3), systemic lupus erythematosus (n = 2), sarcoidosis (n = 1), relapsing polychondritis (n = 1) and anti-neutrophil cytoplasmic antibody -associated vasculitis (n = 1). It was idiopathic in 6 patients. The first biologic agent used in each patient was: adalimumab (n = 6), rituximab (n = 6), infliximab (n = 5) and tocilizumab (n = 2). A second immunosuppressive drug was simultaneously used in 11 patients: methotrexate (n = 11), azathioprine (n = 2), mycophenolate mofetil (n = 1) and hydroxychloroquine (n = 1). Improvement of the main outcomes was observed after 1 year of therapy when compared with baseline data: mean SD BCVA (0.8 0.3 LogMAR vs. 0.6 0.3 LogMAR; p = 0.03), mean SD RNFL (190.5 175.4 m vs. 183.4 139.5 m; p = 0.02), mean SD MT (270.7 23.2 m vs. 369.6 137.4 m; p = 0.03). Besides, the median (IQR) prednisone-dose was also reduced from 40 (10?61.5) mg/day at baseline to. 2.5 (0?5) mg/day after one year of follow-up; p = 0.001. After a mean SD follow-up of 35 months, 15 patients (78.9%) achieved ocular remission, and 2 (10.5%) experienced severe adverse events. Biologic therapy is e ective in patients with refractory non-MS ON

Evidence of association of the NLRP1 gene with giant cell arteritis

Recent studies have focused attention on the involvement of NLRP1 to confer susceptibility for extended autoimmune/inflammatory disorders, being considered a common risk factor in autoimmunity. NLRP1 provides a scaffold for the assembly of the inflammasome that activates caspases 1 and 5, required for processing and activation of the proinflammatory cytokines interleukin 1β (IL-1β), IL-18 and IL-33 and promoting inflammation

Trophic position of dolphins tracks recent changes in the pelagic ecosystem of the Macaronesian region (NE Atlantic)

14 pages, 6 figures, 1 table.-- Open accessDolphins play a key role in marine food webs as predators of mid-trophic-level consumers. Because of their mobility and relatively long life span, they can be used as indicators oflarge-scale changes in the ecosystem. In this study, we calculated the trophic position (TP) of 5 dolphin species from the Canary, Madeira and Azores Islands using bulk and compound-specific stable isotope ratios from muscle tissue to assess trophic adaptations to recent changes in the availability of feeding resources. Dolphin TP values were then compared with those of 7 other species of cetaceans from this region. Analysis of stable nitrogen isotopes in amino acids of the common dolphin indicated non-significant effects of changes in the basal resources of the food web and thus supported the use of bulk samples for TP estimations. Dolphins occupied an intermediate TP (mean: 3.91 to 4.20) between fin (3.25) and sperm whales (4.95). Species-specific TP were equivalent among islands. However, TP increased for the common dolphin and decreased for the bottlenose dolphin (the latter also becoming more oceanic) between 2000 and 2018 in the Canary Islands. These results suggest different impacts of recent changes in the oceanography and in the pelagic food web of the Macaronesian region on the trophic ecology of dolphin speciesThis study was supported in part by the projects QLOCKS (PID2020-115620RB-I00), funded by MCIN/AEI/10.13039/501100011033 (Spain), MISTIC SEAS 2 (‘Applyinga subregional coherent and coordinated approach to the monitoring and assessment of marine biodiversity in Macaronesia for the second cycle of the MSFD’), funded by the Directorate General Environment of the European Commission (Grant Agreement No. 11.0661/2017/750679/SUB/ENV.C2), MISTIC SEAS 3 (‘Developing a coordinated approach for assessing Descriptor 4 via its linkages with D1 and other relevant descriptors in the Macaronesian subregion’), funded by the Directorate General Environment of the European Commission (Grant Agreement No. 110661/2018/794676/SUB/ENV.C2), RACAM (Rede de Arrojamentos de Cetáceos do Arquipélago da Madeira), implemented by the Madeira Whale Museum and funded by the Machico Municipality and projects MARCET (MAC/1.1b/149) and MARCET II (MAC/2.6c/392), both co-financed by EU Programme INTERREG MAC 2014−2020, and through the Commission (28-5307) for ‘Technical scientific advice for the protection of the marine environment: assessment and monitoring of marine strategies, monitoring of marine protected areas of state competence (2018−2021)’ of the Spanish Ministry of Economy and Competitiveness Demographic Challenge (MITECO). Data collection in the Azores was supported by FCT and FRCT through TRACE-PTDC/MAR/74071/2006, MAPCET-M2.1.2/F/012/2011, IF/00943/2013/CP1199/CT0001 (FEDER, COMPETE, QREN, POPH, ESF, Portuguese Ministry for Science and Education, Azores 2020 Operational Programme). M.A.S. was funded by SUMMEREU-H2020 GA 817806. M.A.S. and R.P. were funded by OP AZORES 2020, through the EU Fund 01-0145-FEDER-000140. Okeanos is funded by FCT (UIDB/05634/2020) and by the Regional Government of the Azores (M1.1.A/REEQ.CIENTÍFICO UI&D/2021/010). J.G. was supported by the Spanish National Programme Juan de la Cierva-Formación (MCIN/AEI/10.13039/501100011033 FJC2019-040016-I). This work acknowledges the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S) to the Institute of Marine Science (ICM-CSIC)Peer reviewe

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

OBJECTIVE: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical practice Methods: Observational, open-label multicenter study from 40 national referral centers of GCA patients treated with TCZ due to inefficacy or adverse events of previous therapy. Outcomes variables were improvement of clinical features, acute phase reactants, glucocorticoid-sparing effect, prolonged remission and relapses. A comparative study was performed: (a) TCZ route (SC vs. IV); (b) GCA duration (?6 vs. >6 months); (c) serious infections (with or without); (d) ?15 vs. >15 mg/day at TCZ onset. RESULTS: 134 patients; mean age, 73.0 ± 8.8 years. TCZ was started after a median [IQR] time from GCA diagnosis of 13.5 [5.0-33.5] months. Ninety-eight (73.1%) patients had received immunosuppressive agents. After 1 month of TCZ 93.9% experienced clinical improvement. Reduction of CRP from 1.7 [0.4-3.2] to 0.11 [0.05-0.5] mg/dL (p < 0.0001), ESR from 33 [14.5-61] to 6 [2-12] mm/1st hour (p < 0.0001) and decrease in patients with anemia from 16.4% to 3.8% (p < 0.0001) were observed. Regardless of administration route or disease duration, clinical improvement leading to remission at 6, 12, 18, 24 months was observed in 55.5%, 70.4%, 69.2% and 90% of patients. Most relevant adverse side-effect was serious infections (10.6/100 patients-year), associated with higher doses of prednisone during the first three months of therapy. CONCLUSION: In clinical practice, TCZ yields a rapid and maintained improvement of refractory GCA. Serious infections appear to be higher than in clinical trials